Error: Could not add to watchlist. X

Novogen Ltd

+ Watchlist
NRT:AU
ASE
0.14
AUD
0.00
1.75%
As of 01:34:56 ET on 09/04/2015.
Open
0.15
Day Range
0.14 - 0.15
Volume
305,043
Previous Close
0.14
52Wk Range
0.08 - 0.45
1 Yr Return
-8.86%
Open
0.15
Day Range
0.14 - 0.15
Volume
305,043
Previous Close
0.14
52Wk Range
0.08 - 0.45
1 Yr Return
-8.86%
YTD Return
34.53%
Current P/E Ratio (TTM)
-
Earnings per Share (AUD) (TTM)
-0.03
Market Cap (m AUD)
59.376
Shares Outstanding (m)
424.118
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Novogen Limited is a drug discovery company. The Company owns two proprietary drug technology platforms which include super-benzopyrans and anti-tropomyosins that target broad therapeutic potential across the fields of cancer, musculodegenerative diseases, neurodegenerative diseases, regenerative medicine, lysosomal storage diseases, and autoimmune diseases.
ADDRESS
16 - 20 Edgeworth David Ave
Hornsby, NSW 2077
Australia
PHONE
61-2-9472-4100
  • Iain Gladstone Ross
    Acting CEO
  • Cristyn Humphreys
    Chief Operating Officer
  • David Brown
    Chief Scientific Officer
  • W Andrew Heaton
    Pres & CEO:Novogen North America
  • Lionel Mateo
    Secretary
Show More